Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by TradingMindon Jun 03, 2021 1:37pm
129 Views
Post# 33319920

What's revolutionizing healthcare today?!

What's revolutionizing healthcare today?!Sponsored Post As consumers’ lifestyles are changing and their concerns about health and related activities are increasing, the adoption of the internet of medical things might improve more the coming years. The potential demand of internet of medical things devices faces a lot of challenges in the technological aspects. Nowadays, medical industries produces smart devices, such as wearables for medical monitoring. It could also be use in different places like home, community, clinic or hospital settings and associated real-time location. What really pique my interest is the use of the latest monitoring system that empowers users to self-manage chronic conditions.!

Traditional health care is experiencing a shift as digital transformation places technologically advanced and accessible solutions in the hands of consumers, providing patients and physicians with access to advanced technologies even in the poorest and most remote areas. Medical technological industries exist to give novel data monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic treatments for lifestyle and chronic conditions.
 
As a result, approximately 60% of worldwide health-care institutions have already used Internet of Things technologies.  Some of the device could track key health data, including heart rate, respiration rate, body temperature and sleep patterns. The device provides feedback based on the data, including a readiness score that alerts user to their level of physical performance. Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>